Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo.
about
Gut microbiota and immune crosstalk in metabolic diseaseApolipoprotein E plays a key role against cryptosporidial infection in transgenic undernourished miceApolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis.ApoE plasma levels and risk of cardiovascular mortality in old ageReduction of circulating cholesterol and apolipoprotein levels during sepsis.Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins.Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexesAPOε4 is associated with enhanced in vivo innate immune responses in human subjectsAn expanding role for apolipoprotein E in sepsis and inflammation.ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance.NKT cells in sepsis.Targeted deletion of endothelial lipase increases HDL particles with anti-inflammatory properties both in vitro and in vivo.Apolipoprotein E negatively regulates house dust mite-induced asthma via a low-density lipoprotein receptor-mediated pathway.Hepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE*3-Leiden miceReceptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.Gut microbiota and diabetes: from pathogenesis to therapeutic perspective.Alanyl-glutamine attenuates 5-fluorouracil-induced intestinal mucositis in apolipoprotein E-deficient miceGastrointestinal and hepatic mechanisms limiting entry and dissemination of lipopolysaccharide into the systemic circulation.SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearanceInfection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors.Preoperative apolipoprotein CI levels correlate positively with the proinflammatory response in patients experiencing endotoxemia following elective cardiac surgery.Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein.Learning from biology: synthetic lipoproteins for drug delivery.Deactivation of the lipopolysaccharide antagonist eritoran (E5564) by high-density lipoprotein-associated apolipoproteins.Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease.Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A.Febrile-range temperature modifies early systemic tumor necrosis factor alpha expression in mice challenged with bacterial endotoxin.Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS.LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction.[Gut microbiota and immune crosstalk in metabolic disease].Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation.The Central Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Septic Pathogen Lipid Transport and Clearance.Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection.Protein-free phospholipid emulsion treatment improved cardiopulmonary function and survival in porcine sepsis.Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins.Plasma apolipoprotein CI protects against mortality from infection in old age.Hyperlipoproteinemic low-density lipoprotein receptor-deficient mice are more susceptible to sepsis than corresponding wild-type mice.On the role and fate of LPS-dephosphorylating activity in the rat liver.Host defenses against metabolic endotoxaemia and their impact on lipopolysaccharide detection.Human Apolipoprotein E concentration in response to diseases and therapeutic treatments
P2860
Q28078180-CDD9F3AE-60DB-484B-AA14-2E83B8D8FD95Q30414421-EC129554-465D-405A-9E69-9318D2F31B92Q30425943-4F9C8013-C6BD-4A64-8E17-95EFA740FB79Q33242076-082766C1-5983-4C2B-9069-7AA7D9D95AA8Q33649891-1B6D808C-4FD9-43F7-B307-4214219E044DQ33693897-8E0F3C68-95A5-473C-905E-DA783D173A6BQ33997607-9AEF96E0-6C1D-4E87-8E11-48C8E34291A4Q34017080-0B8B6077-210A-4680-86B1-192F3B56CD0FQ34017328-FFB9E99A-9BD5-49AA-94F0-0D27421578BEQ34053118-07752D25-E62C-454A-A895-EED19DA1C137Q34189487-9FF485A9-6FF6-4404-92D6-B04031C9D305Q34395133-C46F40DF-A379-4513-88AD-6A43774DDCC4Q34402431-78703104-2D9E-4A47-B1FE-F3182971A18FQ34776315-0F6A65B1-66F7-4133-8D35-8E893966A3FCQ35176262-8A9528C8-93EE-4573-8A1E-8218CC853E88Q35573510-FF5C7BE0-6C38-4962-8DBC-A78B06F04AA0Q35750845-8729A841-A156-4FC3-8658-9B375AFDB893Q36010414-D8D1851E-1445-463C-AF0E-B5AE54A620BDQ36227219-6C2F9A29-3F11-4582-B575-198A6BA5C393Q36745042-0D0273E8-C734-49B2-B6AD-014AE29B4D41Q36800299-282DF38D-1A35-4610-96B9-364B10B3E24AQ36994830-7CB37710-8A69-420D-8BC4-AE87B95D35E8Q38262882-A97EF2E6-B109-4BFB-9D93-E2317F32FB58Q38336848-9E1B5FBC-7E80-4DED-B780-EB9B301EBB6FQ38807248-29A72F71-7EE5-4E5A-951E-3CDEB03E004FQ39045016-EB403FAC-F95D-45F7-8F4C-1EA99A9EE846Q39510276-38FB2B2D-D3A1-4320-A9E8-CA9AFABDC12CQ39510738-A77E16E4-E288-481A-ADF7-7B8FE09DC745Q39906364-D76BEB12-7627-4345-A149-C5651EFA3221Q40145683-400E884F-A6AB-4EEE-95E9-893E0A9B36E0Q40665206-9F8AF98D-F121-44C1-A2D3-00A295461CCBQ41064722-F3981545-F7E7-46F7-9BDE-520569D07CD5Q43039746-6BFCBEAC-F16D-4365-8315-598BD60A6753Q43446963-93A89A26-1856-4ED1-ADB7-6B9BE0AB3981Q43500997-171486D8-3B5E-465B-829B-44F7204498F3Q44179480-D9713AB8-9D99-476E-A6A8-412522BAB558Q44735213-9559D225-F87A-4BC9-8A3B-C3E2BB400E8AQ46751975-FC7CCEB2-AA36-460F-8C9A-A0106C4473D0Q53122566-51B5C057-E720-4635-82B5-CCD2820CB965Q57995824-ECE5A306-F71D-40B9-80C1-C09B1CB85E95
P2860
Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human recombinant apolipoprote ...... nchymal cells in rats In vivo.
@en
Human recombinant apolipoprote ...... nchymal cells in rats In vivo.
@nl
type
label
Human recombinant apolipoprote ...... nchymal cells in rats In vivo.
@en
Human recombinant apolipoprote ...... nchymal cells in rats In vivo.
@nl
prefLabel
Human recombinant apolipoprote ...... nchymal cells in rats In vivo.
@en
Human recombinant apolipoprote ...... nchymal cells in rats In vivo.
@nl
P2093
P2860
P356
P1476
Human recombinant apolipoprote ...... enchymal cells in rats In vivo
@en
P2093
P2860
P304
P356
10.1172/JCI119427
P407
P50
P577
1997-05-01T00:00:00Z